Sponsor: MUSC
Sponsor Study ID: 103909
Study Title: A Phase II study of Fingolimod in Patients with Non-Small Cell and Small Cell Lung Cancer
CTO #: 103909
NCT Number:
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Lung
Study Objectives: To determine the safety and tolerability of fingolimod in patients with NSCLC and SCLC. To evaluate the objective response rate (ORR) (when measurable) according to RECIST 1.1 criteria